Clinically validated Seegene HPV assays
Anyplex™ II HPV HR and HPV28 Detection are designed to identify 14 and/or 28 different HPV types in a single specimen and fulfill all clinical requirements for the primary cervical cancer screening.
The clinical performance of Anyplex™ II HPV HR Detection showed comparable outcomes with Hybrid Capture 2 HPV DNA test (HC2) and Cobas 4800 HPV test (Cobas) in VALGENT-3 study.
Reference - Ostrbenk et al. (2018) Journal of Clinical Microbiology
Anyplex™ II HPV HR Detection fulfills the international consensus validation metrics for HPV DNA tests for cervical cancer screening.
Reference - Hessenlink AT et al. Journal of Clinical Virology (2016) 76:36-39, Meijer CJLM et al. Int J Cancer (2009)124(3):516~20
Anyplex™ II HPV28 Detection had 100% proficient results for HPV type detection from all participants in the WHO HPV LabNet international proficiency study.
Reference - Carina EKlund et al. Journal of Clinical Virology (2018) 101:74-85
Anyplex™II HPV HR and HPV28 Detection can be applied on Seegene's automation platform, which streamlines and optimizes the workflow of HPV genotyping and screening.